Back to Search Start Over

Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells.

Authors :
Lamboy-Caraballo R
Ortiz-Sanchez C
Acevedo-Santiago A
Matta J
N A Monteiro A
N Armaiz-Pena G
Source :
International journal of molecular sciences [Int J Mol Sci] 2020 Mar 24; Vol. 21 (6). Date of Electronic Publication: 2020 Mar 24.
Publication Year :
2020

Abstract

Multiple studies have shown that psychological distress in epithelial ovarian cancer (EOC) patients is associated with worse quality of life and poor treatment adherence. This may influence chemotherapy response and prognosis. Moreover, although stress hormones can reduce cisplatin efficacy in EOC treatment, their effect on the integrity of DNA remains poorly understood. In this study, we investigated whether norepinephrine and epinephrine can induce DNA damage and modulate cisplatin-induced DNA damage in three EOC cell lines. Our data show that norepinephrine and epinephrine exposure led to increased nuclear γ-H2AX foci formation in EOC cells, a marker of double-strand DNA breaks. We further characterized norepinephrine-induced DNA damage by subjecting EOC cells to alkaline and neutral comet assays. Norepinephrine exposure caused DNA double-strand breaks, but not single-strand breaks. Interestingly, pre-treatment with propranolol abrogated norepinephrine-induced DNA damage indicating that its effects may be mediated by β-adrenergic receptors. Lastly, we determined the effects of norepinephrine on cisplatin-induced DNA damage. Our data suggest that norepinephrine reduced cisplatin-induced DNA damage in EOC cells and that this effect may be mediated independently of β-adrenergic receptors. Taken together, these results suggest that stress hormones can affect DNA integrity and modulate cisplatin resistance in EOC cells.

Details

Language :
English
ISSN :
1422-0067
Volume :
21
Issue :
6
Database :
MEDLINE
Journal :
International journal of molecular sciences
Publication Type :
Academic Journal
Accession number :
32213975
Full Text :
https://doi.org/10.3390/ijms21062250